Mortality associated with mifepristone-misoprostol medical abortion.
Creinin
Mitchell
M
Gynecology and Reproductive Sciences, Division of Gynecologic Specialties, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Blumenthal
Paul
P
Shulman
Lee
L
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000028:Abortion, Induced / Q000401:mortality*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D016595:Misoprostol / Q000009:adverse effects*; D011247:Pregnancy
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone